Warp Speed For All And A Boost For Small Biotechs In Trump’s Second Term, Ex-Official Says

 
• By Sarah Karlin-Smith
  
Training moving fast.
The FDA may aim to speed up agency reviews during Trump's second term. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Elections

More from Legislation